IRON · Company research

Disc Medicine, Inc. Common Stock (IRON): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

24records availableHealthcare

Stock News & Events data

Database-backed records only

24 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)Disc Medicine announced it will host a webcast on October 19, 2026 to discuss topline results from the APOLLO Phase 3 trial of bitopertin in EPP. Bitopertin is an investigational oral GlyT1 inhibitor designed to modulate heme biosynthesis and has potential to be the first disease-modifying therapy for erythropoietic porphyrias.View source ↗GlobeNewswire Inc.Oct 18, 2026bullish11
Champion Iron stock falls 3.35 percent to EUR 1.73, UBS target sits 51.26 percent higher - ad-hoc-news.deChampion Iron stock falls 3.35 percent to EUR 1.73, UBS target sits 51.26 percent higher ad-hoc-news.deView source ↗ad-hoc-news.deOct 17, 2026neutral00.6
Disc Medicine (NASDAQ:IRON) Stock Gets Downgrade from Wall Street Zen - MarketBeatDisc Medicine (NASDAQ:IRON) Stock Gets Downgrade from Wall Street Zen MarketBeatView source ↗MarketBeatOct 17, 2026neutral00.6
Here’s How Much You Would Have Made Owning Iron Mountain Stock In The Last 5 Years - BenzingaHere’s How Much You Would Have Made Owning Iron Mountain Stock In The Last 5 Years BenzingaView source ↗BenzingaOct 16, 2026neutral00.6
Disc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Target Price of $110.18 - MarketBeatDisc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Target Price of $110.18 MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
Disc Medicine (Nasdaq:IRON) - Stock Analysis - Simply Wall StreetDisc Medicine (Nasdaq:IRON) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 15, 2026neutral00.6
Understanding Momentum Shifts in (IRON) - Stock Traders DailyUnderstanding Momentum Shifts in (IRON) Stock Traders DailyView source ↗Stock Traders DailyOct 12, 2026neutral00.6
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - StocktwitsDisc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns StocktwitsView source ↗StocktwitsOct 11, 2026neutral00.6
Iron Horse Acquisitions II Corp. (NASDAQ:IRHO) Stock Short Interest Report for September - MarketBeatIron Horse Acquisitions II Corp. (NASDAQ:IRHO) Stock Short Interest Report for September MarketBeatView source ↗MarketBeatOct 11, 2026neutral00.6
Iron Mountain Inc. stock outperforms competitors on strong trading day - MarketWatchIron Mountain Inc. stock outperforms competitors on strong trading day MarketWatchView source ↗MarketWatchOct 9, 2026neutral00.6
Watani Iron Steel (SASE:1325) - Stock Analysis - Simply Wall StreetWatani Iron Steel (SASE:1325) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 9, 2026neutral00.6
Iron Mountain Inc. stock underperforms Thursday when compared to competitors - MarketWatchIron Mountain Inc. stock underperforms Thursday when compared to competitors MarketWatchView source ↗MarketWatchOct 8, 2026neutral00.6
Champion Iron stock heads toward October 28 results after Q1 loss - AD HOC NEWSChampion Iron stock heads toward October 28 results after Q1 loss AD HOC NEWSView source ↗AD HOC NEWSOct 8, 2026neutral00.6
Central Iron Ore Limited (CIO.V) Stock Price, News, Quote & History - Yahoo! Finance CanadaCentral Iron Ore Limited (CIO.V) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 7, 2026neutral00.6
Iron Mountain Inc. stock outperforms competitors on strong trading day - MarketWatchIron Mountain Inc. stock outperforms competitors on strong trading day MarketWatchView source ↗MarketWatchOct 6, 2026neutral00.6
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your RightsThe Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) following an FDA Complete Response Letter on February 13, 2026, regarding its bitopertin program. The FDA stated it could not approve the new drug application due to uncertainties requiring additional evidence. Disc Medicine's stock price fell 22% on the news. The firm is preparing a class action lawsuit to recover investor losses.View source ↗GlobeNewswire Inc.Oct 5, 2026bearish-11
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your RightsThe Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) following an FDA Complete Response Letter on February 13, 2026, regarding its bitopertin program. The FDA stated it could not approve the new drug application due to uncertainties requiring additional evidence. Disc Medicine's stock price fell 22% on the news. The firm is preparing a class action lawsuit to recover investor losses.View source ↗GlobeNewswire Inc.Oct 5, 2026bearish-11
Understanding Momentum Shifts in (IRON) - Stock Traders DailyUnderstanding Momentum Shifts in (IRON) Stock Traders DailyView source ↗Stock Traders DailyOct 2, 2026neutral00.6
Iron Mountain (IRM) Stock Still Looks Cheap Against Future Cash Flow - Simply Wall StreetIron Mountain (IRM) Stock Still Looks Cheap Against Future Cash Flow Simply Wall StreetView source ↗Simply Wall StreetSep 30, 2026neutral00.6
Iron Mountain (IRM) Stock Could Be 36% Below Fair Value Despite AI Recognition - Yahoo FinanceIron Mountain (IRM) Stock Could Be 36% Below Fair Value Despite AI Recognition Yahoo FinanceView source ↗Yahoo FinanceSep 29, 2026neutral00.6
Rothschild Redburn initiates Iron Mountain stock with buy rating - Investing.comRothschild Redburn initiates Iron Mountain stock with buy rating Investing.comView source ↗Investing.comSep 21, 2026neutral00.6
Jim Cramer on Iron Mountain (IRM): “It’s Been an Incredible Stock” - Yahoo FinanceJim Cramer on Iron Mountain (IRM): “It’s Been an Incredible Stock” Yahoo FinanceView source ↗Yahoo FinanceSep 20, 2026neutral00.6
Disc Medicine (NASDAQ: IRON) CEO turns 36,000 options into stock - Stock TitanDisc Medicine (NASDAQ: IRON) CEO turns 36,000 options into stock Stock TitanView source ↗Stock TitanSep 16, 2026neutral00.6
Best Iron Stocks of 2026 and How to Invest in Them - The Motley FoolBest Iron Stocks of 2026 and How to Invest in Them The Motley FoolView source ↗The Motley FoolSep 10, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.